Black Rock Inc. Denali Therapeutics Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 13,174,562 shares of DNLI stock, worth $174 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,174,562

Previous 12,199,856 7.99%

Holding current value

$174 Million

Previous $250 Million 22.2%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $14.6 Million - $22.6 Million	974,706 Added 7.99%	13,174,562 $306 Million
Q1 2024 May 10, 2024	BUY	$15.83 - $23.35 $10.4 Million - $15.3 Million	656,410 Added 5.69%	12,199,856 $250 Million
Q4 2023 Feb 13, 2024	BUY	$16.2 - $23.18 $10.7 Million - $15.3 Million	658,150 Added 6.05%	11,543,446 $248 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $16.1 Million - $23.5 Million	779,021 Added 7.71%	10,885,296 $225 Million
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $14.8 Million - $20.8 Million	631,878 Added 6.67%	10,106,275 $298 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $3.34 Million - $4.98 Million	152,383 Added 1.63%	9,474,397 $218 Million
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $19 Million - $24.6 Million	723,802 Added 8.42%	9,322,014 $259 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $4.84 Million - $7.18 Million	-186,420 Reduced 2.12%	8,598,212 $264 Million
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $12.5 Million - $21.1 Million	598,892 Added 7.32%	8,784,632 $259 Million
Q1 2022 May 12, 2022	BUY	$29.0 - $47.27 $2.17 Million - $3.54 Million	74,918 Added 0.92%	8,185,740 $263 Million
Q4 2021 Feb 10, 2022	BUY	$42.59 - $55.02 $23.4 Million - $30.3 Million	549,985 Added 7.27%	8,110,822 $362 Million
Q3 2021 Nov 09, 2021	BUY	$48.48 - $78.23 $25.4 Million - $41.1 Million	524,796 Added 7.46%	7,560,837 $381 Million
Q2 2021 Aug 11, 2021	BUY	$50.3 - $78.44 $354 Million - $552 Million	7,036,041 New	7,036,041 $552 Million

Others Institutions Holding DNLI

# of Institutions

234

Shares Held

127M

Call Options Held

37.3K

Put Options Held

7.9K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.78B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account